Medicine and Health
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants
Y. Kang, C. Sun, et al.
Innovative research led by Yin-Feng Kang and colleagues introduces a quadrivalent mosaic nanoparticle vaccine that shows promise against emerging SARS-CoV-2 variants. This vaccine elicits strong immune responses and offers protection against various strains, paving the way for enhanced multivalent vaccines to combat future viral threats.
Related Publications
Explore these studies to deepen your understanding of the subject.

